Dishman Pharmaceuticals and Chemicals spurted 10.20% to Rs 76.15 at 10:23 IST on BSE, extending Thursday's 9.08% spurt triggered by the company's strong Q2 September 2013 results.
The company announced results during trading hours on Thursday, 31 October 2013. The stock spurted 9.08% to Rs 69.10 on that day. The stock has risen 20.21% in two sessions from Rs 63.35 on 30 October 2013.
Meanwhile, the BSE Sensex was up 27.90 points, or 0.13%, to 21,192.42.
On BSE, 4.94 lakh shares were traded in the counter compared with average volume of 1.70 lakh shares in the past one quarter.
The stock hit a high of Rs 78.50 and a low of Rs 68.90 so far during the day. The stock hit a 52-week high of Rs 124.50 on 5 December 2012. The stock hit a 52-week low of Rs 37.05 on 2 August 2013.
The stock had outperformed the market over the past one month till 31 October 2013, rising 33.27% compared with the Sensex's 9.21% rise. The scrip had also outperformed the market in past one quarter, gaining 60.32% as against Sensex's 9.40% rise.
The small-cap company has an equity capital of Rs 16.14 crore. Face value per share is Rs 2.
On a consolidated basis, Dishman Pharmaceuticals and Chemicals' net profit jumped 58.97% to Rs 42.27 crore on 19.49% increase in total income from operations (net) to Rs 354.95 crore in Q2 September 2013 over Q2 September 2012.
Dishman is the global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and manufacturing services. The products and services offered by the company spans from chemical development to commercial manufacture and supply of active pharmaceutical ingredients.
Powered by Capital Market - Live News